IN2014DN09314A - - Google Patents
Info
- Publication number
- IN2014DN09314A IN2014DN09314A IN9314DEN2014A IN2014DN09314A IN 2014DN09314 A IN2014DN09314 A IN 2014DN09314A IN 9314DEN2014 A IN9314DEN2014 A IN 9314DEN2014A IN 2014DN09314 A IN2014DN09314 A IN 2014DN09314A
- Authority
- IN
- India
- Prior art keywords
- processes
- formula
- pfiol
- aria
- quinolone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1206280.8A GB201206280D0 (en) | 2012-04-10 | 2012-04-10 | Anti-malarial agents |
| PCT/GB2013/050633 WO2013153357A1 (fr) | 2012-04-10 | 2013-03-14 | Agents antipaludéens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09314A true IN2014DN09314A (fr) | 2015-07-10 |
Family
ID=46177063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9314DEN2014 IN2014DN09314A (fr) | 2012-04-10 | 2013-03-14 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9115088B2 (fr) |
| EP (1) | EP2836483B1 (fr) |
| JP (1) | JP6088639B2 (fr) |
| CN (1) | CN104302624B (fr) |
| BR (1) | BR112014025416B1 (fr) |
| CA (1) | CA2870140C (fr) |
| ES (1) | ES2587683T3 (fr) |
| GB (1) | GB201206280D0 (fr) |
| HU (1) | HUE030572T2 (fr) |
| IN (1) | IN2014DN09314A (fr) |
| MY (1) | MY166153A (fr) |
| PH (1) | PH12014502285A1 (fr) |
| PT (1) | PT2836483T (fr) |
| SG (1) | SG11201406548WA (fr) |
| WO (1) | WO2013153357A1 (fr) |
| ZA (1) | ZA201408094B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201610724D0 (en) | 2016-06-20 | 2016-08-03 | Univ Dundee | Anti-infective agents |
| CN108101842B (zh) * | 2017-12-29 | 2021-04-30 | 山东诚汇双达药业有限公司 | 一种2-羟基-4-羧基喹啉的制备方法 |
| US11491162B2 (en) | 2018-04-11 | 2022-11-08 | Merck Patent Gmbh | Combination of quinoline-4-carboxamides and benzonaphthyridine derivatives as antimalarial drug combination |
| CN111084774B (zh) * | 2019-11-29 | 2021-06-15 | 中国科学院广州生物医药与健康研究院 | 吡咯烷类化合物组合物在制备抗疟疾药物中的应用 |
| US20230108442A1 (en) * | 2020-01-21 | 2023-04-06 | Eisai R&D Management Co., Ltd. | Novel antimalarial agent containing heterocyclic compound |
| EP3892332A1 (fr) * | 2020-04-09 | 2021-10-13 | University Of Kentucky Research Foundation | Nouveaux agents anti-paludiques |
| WO2024089045A1 (fr) * | 2022-10-24 | 2024-05-02 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Molécules imitant tasl et leurs applications |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2502264A (en) * | 1946-06-25 | 1950-03-28 | Us Sec War | Quinoline derivatives having antimalarial properties |
| JPH0873355A (ja) * | 1994-09-02 | 1996-03-19 | Mitsui Toatsu Chem Inc | 抗マラリア薬耐性克服剤 |
| KR100263802B1 (ko) * | 1995-11-16 | 2001-01-15 | 프리돌린 클라우스너, 롤란드 비. 보레르 | 항말라리아성 퀴놀린 유도체 |
| JP2002505689A (ja) * | 1997-06-19 | 2002-02-19 | セプレイコー インコーポレイテッド | キノリン−インドール抗菌剤、それらに関する用途及び組成物 |
| CN101300241A (zh) * | 2005-10-21 | 2008-11-05 | 埃科特莱茵药品有限公司 | 作为抗疟疾剂的哌嗪衍生物 |
-
2012
- 2012-04-10 GB GBGB1206280.8A patent/GB201206280D0/en not_active Ceased
-
2013
- 2013-03-14 EP EP13711110.0A patent/EP2836483B1/fr active Active
- 2013-03-14 SG SG11201406548WA patent/SG11201406548WA/en unknown
- 2013-03-14 CA CA2870140A patent/CA2870140C/fr active Active
- 2013-03-14 IN IN9314DEN2014 patent/IN2014DN09314A/en unknown
- 2013-03-14 BR BR112014025416A patent/BR112014025416B1/pt active IP Right Grant
- 2013-03-14 CN CN201380025617.2A patent/CN104302624B/zh active Active
- 2013-03-14 PT PT137111100T patent/PT2836483T/pt unknown
- 2013-03-14 WO PCT/GB2013/050633 patent/WO2013153357A1/fr active Application Filing
- 2013-03-14 US US14/391,394 patent/US9115088B2/en active Active
- 2013-03-14 MY MYPI2014002888A patent/MY166153A/en unknown
- 2013-03-14 HU HUE13711110A patent/HUE030572T2/en unknown
- 2013-03-14 JP JP2015505014A patent/JP6088639B2/ja active Active
- 2013-03-14 ES ES13711110.0T patent/ES2587683T3/es active Active
-
2014
- 2014-10-10 PH PH12014502285A patent/PH12014502285A1/en unknown
- 2014-11-05 ZA ZA2014/08094A patent/ZA201408094B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB201206280D0 (en) | 2012-05-23 |
| CN104302624B (zh) | 2016-01-13 |
| BR112014025416A2 (pt) | 2013-10-17 |
| JP6088639B2 (ja) | 2017-03-01 |
| CA2870140C (fr) | 2018-06-26 |
| ES2587683T3 (es) | 2016-10-26 |
| BR112014025416A8 (pt) | 2018-06-12 |
| PH12014502285B1 (en) | 2014-12-15 |
| BR112014025416B1 (pt) | 2020-04-22 |
| WO2013153357A1 (fr) | 2013-10-17 |
| JP2015512930A (ja) | 2015-04-30 |
| EP2836483B1 (fr) | 2016-07-27 |
| ZA201408094B (en) | 2017-08-30 |
| PH12014502285A1 (en) | 2014-12-15 |
| PT2836483T (pt) | 2016-08-26 |
| HUE030572T2 (en) | 2017-05-29 |
| MY166153A (en) | 2018-06-06 |
| CA2870140A1 (fr) | 2013-10-17 |
| US9115088B2 (en) | 2015-08-25 |
| CN104302624A (zh) | 2015-01-21 |
| US20150045354A1 (en) | 2015-02-12 |
| SG11201406548WA (en) | 2015-01-29 |
| EP2836483A1 (fr) | 2015-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501385A1 (en) | Autotaxin inhibitors | |
| PH12014502597A1 (en) | N-substituted benzamides and their use in the treatment of pain | |
| MX348422B (es) | Inhibidores de arginasa y sus aplicaciones terapeuticas. | |
| EA201500652A1 (ru) | Дифторметилникотиновые инданилкарбоксамиды | |
| PH12015500347A1 (en) | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
| MD20150043A2 (ro) | Inhibitori ai histon-demetilazelor | |
| EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
| MX336381B (es) | Boronatos como inhibidores de arginasa. | |
| PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
| PH12014000179A1 (en) | New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them | |
| PH12014502285A1 (en) | Anti-malarial agents | |
| NZ707203A (en) | Triazolopyrazine | |
| MY186599A (en) | Substituted pyridopyrazines as novel syk inhibitors | |
| PH12015501609A1 (en) | Phenicol antibacterials | |
| PH12015501175A1 (en) | Substituted pyridopyrazines as syk inhibitors | |
| MX2015001099A (es) | Nuevos derivados biciclicos de piridina. | |
| GEP201706621B (en) | Benzamides | |
| TW201613864A (en) | Novel compounds | |
| MY166449A (en) | Pharmaceutical composition of rosuvastatin calcium | |
| PH12015501038A1 (en) | Inhibitors of iap | |
| MX362879B (es) | Usos novedosos. | |
| MX367309B (es) | Nuevos compuestos antibacterianos. | |
| MX363480B (es) | Compuestos bacterianos que constan de un grupo heterocicloalquilo basado en nitrógeno que contiene un doble enlace unido a carbonilo que inhiben la enzima fabi. | |
| IN2015DN02109A (fr) | ||
| MX348841B (es) | Derivados de pirimidooxazocina como inhibidores de mtor. |